Latest Morning Briefing Stories
How Pfizer Won the Pandemic, Reaping Outsize Profit and Influence
The drugmaker has the best-selling vaccine to prevent covid and the most effective drug to treat it. Its success has overshadowed the government’s covid-fighting strategy.
Cómo Pfizer le ganó a la pandemia, alcanzando influencia y ganancias descomunales
Su éxito en el desarrollo de medicamentos contra covid le ha dado a la farmacéutica un peso inusual en la determinación de la política de salud de Estados Unidos. Algo que preocupa a expertos.
Montana’s Blackfeet Tribe to Use Dogs to Sniff Out Disease and Contaminants
The Blackfeet Nation is experimenting with a new way to detect chronic wasting disease in animals used by tribal members for food and cultural practices.
LA’s First Heat Officer Says Helping Vulnerable Communities Is Key to Achieving Climate Goals
Los Angeles taps Marta Segura, director of the city’s climate emergency mobilization office, as its first heat officer. Segura, the first Hispanic person to hold such a position in the country, will work across city departments on an early warning system while developing cooling strategies.
El calor extremo puede causar calambres, agotamiento por calor e insolación. El calor extremo contribuyó a la muerte de unas 12,000 personas en Estados Unidos cada año entre 2010 y 2020, según un estudio de la Universidad de Washington. Es probable que esas cifras aumenten.
Tribu entrena perros para detectar enfermedades y contaminantes
El proyecto pretende proteger la salud de los miembros de la tribu haciéndoles saber dónde se ha detectado la enfermedad y dónde se han encontrado residuos tóxicos, y preservar así espacios seguros para la realización de prácticas tradicionales.
What You Need to Know About Monkeypox
For now, monkeypox poses a low risk to the U.S. public, but it could become a problem if the spread is left unchecked. Here’s what everyone should know about it.
Lo que debes saber sobre la viruela del simio
Generalmente es una enfermedad leve, pero puede ser grave o incluso mortal para las personas inmunodeprimidas, embarazadas, fetos o recién nacidos, mujeres lactantes, niños pequeños y personas con enfermedades de la piel, como eccema.
KHN’s ‘What the Health?’: The FDA Goes After Nicotine
The FDA is using its power to regulate tobacco products — ordering the vaping device Juul off the market and announcing its intention to lower the amount of nicotine in cigarettes and other products. Meanwhile, the Supreme Court rules on Medicare and kidney dialysis, and Congress makes progress on legislation surrounding guns and mental health. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Noam N. Levey about the new KHN-NPR project on the growing impact of medical debt.
Health Care Startups Turn to ‘Coaches’ to Help Patients Cope and Monitor Treatment
The interest, and investment, in coaching and encouragement is a curious turn for an industry that likes to boast of its billion-dollar pills and sophisticated artificial intelligence.